Y 05460M-A
Alternative Names: Y-05460M-ALatest Information Update: 09 Aug 2002
At a glance
- Originator Yamanouchi
- Class Cytostatic antibiotics
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Cancer
Most Recent Events
- 04 Mar 1999 New profile
- 04 Mar 1999 Preclinical development for Cancer in Japan (Unknown route)